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Abstract: We report on a prospective study undertaken in April 2008, in 11 leper villages of 
the Southern Cameroon. Our aim was to determine the prevalence and the causes of bilateral 
blindness, low vision and unilateral blindness in the population of leprosy patients, irrespective 
of the clinical aspects of the illness.
Results: Two hundred thirty-ﬁ  ve known and newly diagnosed leprosy patients were examined. 
These patients included 149 cases (63.4%) of multibacillary leprosy and 86 cases (36.6%) of 
paucibacillary leprosy. There were 111 case of visual handicap, representing 47.2% of the 
population. These visual handicap cases were subdivided into 45 cases (19%) of bilateral blind-
ness, 35 cases (15%) of unilateral blindness and 31 cases (13.2%) of low vision.
Discussion: The prevalence of visual handicap among leprosy patients in Cameroon is too 
high. Causes in the majority of cases are age-related degenerative pathologies, and one third of 
cases are linked to the leprosy mycobacterium.
Conclusion: Discovering a cure for ophthalmic pathologies is important in order to provide a 
better quality of life for this particular population.
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Introduction
Leprosy is caused by a resistant acid-fast bacillus, Mycobacterium leprae, isolated in 
1873 by the Norwegian doctor, Hansen. The bacillus is transmitted among humans, 
who are the sole reservoirs of the bacillus.1 This scourge is considered an old com-
panion, and the effects suffered by humanity include mutilation, disﬁ  gurement and 
blindness. In African and Asian literature, we ﬁ  nd high rates of visual handicap in the 
population of leprosy patients.2–5 No data are available on the prevalence and causes of 
visual handicap in those affected by leprosy in Cameroon. Our aim was to determine 
the prevalence and causes of bilateral blindness, low vision and unilateral blindness 
in the leper population, irrespective of the clinical forms of the disease.
Methodology
This prospective and descriptive study was conducted from April 1st to 31st, 2008, in four 
regions of Cameroon: the centre, south, west and littoral regions, which comprise 11 leper 
villages (Ayos, Mbalmayo, Nyamsong, Ngallan-Ebolowa, Mvoutessi, Sangmelima, 
Nkonmelen, Baleng, Koutaba, Ombessa and Dibamba). The medical team comprised 
an ophthalmologist, an ophthalmic nurse, and two nurses who specialized in leprosy.
After we had obtained their consent, patients were regrouped in their leper villages, 
interviewed, and given a complete ophthalmologic examination (distant visual acuity 
using the Snellen chart, and near visual acuity according to the Parinaud scale; 
biomicroscopy; gonioscopy with a Goldmann three mirror lens, direct ophthalmoscopy 
and measuring of the intraocular pressure using a tonopen). Corneal sensation was 
tested by approaching the eye from the side with a piece of cotton-wool while the patient Clinical Ophthalmology 2009:3 196
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was looking straight ahead. Old and new patients undergoing 
or at the end of their treatment were included.
The World Health Organization (WHO) classiﬁ  cation 
(or staging) of blindness and low vision was used.
–  Bilateral blindness is deﬁ  ned as visual acuity of less than 
3/60 (1/20) from the corrected better eye.
–  Low vision is deﬁ  ned as visual acuity of less than 6/18 
(3/10), but equal or superior to 3/60 (1/20) for the better 
eye with better correction.
We considered a patient to be unilaterally blind, when 
visual acuity of the better eye was superior or equal to 6/18 
(3/10), and the other eye had visual acuity of less than 3/60 
(1/20) with better correction.
We used the Epi Info 6.04 programme to analyze the 
different variables (sex, age, clinical form, treatment, past 
history, bilateral blindness, unilateral blindness, low vision). 
The correlation was statistically signiﬁ  cant when the test was 
inferior to 0.05.
Results
Two hundred thirty-ﬁ  ve leprosy patients (old and new), living 
in the 11 leper villages cited above were examined, including 
118 males (50.2%) and 117 females (49.8%) (Table 1). Their 
ages ranged from 9 to 99 years with a mean age of 65.32 ± 
13.15 years; the age most represented was that above 60 years 
(174 patients; 77%). 149 patients (63.4%) had multibacillary 
leprosy, and 86 (36.6%) had paucibacillary leprosy. Leprosy 
in 231 patients (98.3%) had healed; two cases of relapse and 
two new cases were still undergoing treatment. The treatment 
commonly received was monochemotherapy with Dapsone 
92.8%, while 7.2% had received polychemotherapy. Some 
current general pathologies we found included 12 cases of 
high blood pressure and one diabetic type II patient.
Two patients had had cataract surgery. The main ophthalmic 
complaint was decrease of visual acuity (89.8%). According 
to far visual acuity with the better correction, we counted 
111 visual handicaps (61 males and 50 females), which is 47.2% 
of the total study population. There were 77 cases of multi-
bacillary leprosy and 34 cases of paucibacillary leprosy, and 
45 cases of binocular blindness (19%), 35 cases of monocular 
blindness (15%), and 31 cases of low vision (13.2%).
Out of the 470 eyes examined, 270 (57.4%) presented 
some lesions. The most common ocular lesions seen were 
cataract in 135 eyes (28.7%), age-related macular degenera-
tion (ARMD) in 44 eyes (9.3%), glaucoma in 37 eyes (7.9%) 
and phthisis bulbi in 26 eyes (5.5%) (Table 4). Out of the 
135 cases of cataract, six were secondary cataracts due to 
chronic uveitis.
The leading adnexae lesions were madarosis and alopecia 
(66 cases) (28%), followed by ectropion in 12 cases (5.1%), 
lagophtalmia due to seventh nerve palsy in 10 cases (4.2%) 
and corneal anesthesia 10 cases (4.2%).
The main causes of visual handicap were phthisis bulbi 
and cataract for unilateral blindness; cataract, glaucoma and 
phthisis bulbi for bilateral blindness; and cataract, ARMD and 
glaucoma for low vision (Table 2). No trachoma lesions were 
found in these patients. In the endemic area of onchocerciasis, 
we found four eyes blinded by onchocerciasis retinitis.
Visual handicap supposedly due to leprosy (phthisis bulbi, 
corneal opacity, secondary cataract, secondary glaucoma, and 
acute iridocyclitis) was observed in 55 eyes of 39 patients 
(35%) in the 111 handicap cases (Table 3).
Discussion
A statistically insigniﬁ  cant slight male predominance was 
observed (p = 0.94). This male predominance in a popula-
tion of lepers has been shown in many recent studies.2,6,7 
The population in our series is aging, with an average of 
65 years; this aging has already been described by Mvogo 
Table 1 Age and sex distributions
N = 235 N = 111
Age (years) Leprosy patients Handicaps
 Male Female Male Female
0–19 2 2 1 0
20–39 3 2 1 1
40–59 28 24 9 6
60+ 85 89 50 43
Total 118 117 61 50






Cataract 10 (28.6%) 19 (42.2%) 15 (48.4%)
Glaucoma 4 (11.4%) 10 (22.2%) 4 (13%)
Phthisis bulbi 12 (34.3%) 7 (15.6%) –
ARMD – 4 (8.9%) 7 (22.6%)
Corneal opacities 6 (17.1%) 3 (6.7%) 2 (6.4%)
Onchocerciasis 
retinitis
– 2 (4.4%) –
Macular hole 2 (5.7%) – –
Panuveitis 1 (2.8%) – 1 (3.2%)
Bilateral aphakia – – 1 (3.2%)
Optic neuropathy – – 1 (3.2%)
Total 35 (100%) 45 (100%) 31 (100%)Clinical Ophthalmology 2009:3 197
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and colleagues7 who found a mean age of 59.4 years in the 
same region of Cameroon. Yet this advanced age is quite 
comprehensible. Lepers receive assistance from nongov-
ernmental organizations, and also beneﬁ  t from the National 
Programme for leprosy control, managed by the Cameroon 
Ministry of Public Health. Ministry statistics reveal that the 
disease may even be eradicated in Cameroon, with a preva-
lence of 0.26 per ten thousand in 2007.8
This study supports the ﬁ  nding (p = 0.00006) of many 
studies which have identiﬁ  ed multibacillary leprosy as being 
the most frequent clinical form.2,8–12 Mvogo and colleagues,7 
however, found that paucibacillary leprosy was the most 
frequent form.
Ocular ﬁ  ndings
Cataract was the most frequent intraocular lesion. This ﬁ  nd-
ing is explained by the aging of the population of lepers, who 
develop degenerative pathologies later in life. This hypothesis 
is supported by the results of Mpyet and colleagues,2 who 
showed that cataract was the main ocular pathology. Corneal 
opacities and cataract were the leading ocular pathologies in 
the study by Mvogo and colleagues.7 Madarosis and alopecia 
were the leading adnexal lesions, as already described.7
The prevalence of visual handicap in this population is 
very high, which is a result of the absence of ophthalmic care 
of these patients who are conﬁ  ned in their leper villages. The 
rates of bilateral blindness and low vision are 4 to 10 times 
higher than the rate in the general population: as estimated 
by WHO in 1997, at 1.4% for bilateral blindness and 4.5% 
for low vision.13 In other developing countries, the rate of 
visual handicap is slightly lower, for example, 8.7% of bilat-
eral blindness in northeastern Nigeria,3 and 7.7% of bilateral 
blindness in China.4 The prevalence of unilateral blindness 
in our study was 15%, which we consider a very high rate 
compared with the 4.4% observed in China.4 The prevalence 
of low vision was 13.2%, not too far from the Chinese rate 
of 9.28%,4 as opposed to the low prevalence of 4.4% found 
in Uganda.14
Cataract was the main cause of low vision in our study, 
similar to that observed in Nigeria and China;2,4 followed by 
ARMD and glaucoma. These conditions are mainly age-related 
degenerative pathologies, and are common in both aging 
lepers and normal people. Corneal opacities and optic neuropa-
thies of the 4th and 5th positions could result from leprosy.
According to WHO in 1997,15 the leading causes of 
bilateral blindness in sub-Saharan Africa are cataract, 
trachoma, and glaucoma. This study supported this ﬁ  nding 
for cataract and glaucoma. Hogeweg and colleagues16 showed 
that age-related cataract has become the leading cause of 
blindness in the leprosy population, contrary to the ﬁ  nding 
of Yang and colleagues5 that leucoma and corneal ulcers are 
the main causes of blindness in lepers. The provision of an 
adequate cataract surgical service could nearly halve the 
burden of blindness in this population. Phthisis bulbi and 
corneal opacities, taking the 3rd and the 5th positions of bilat-
eral blindness, are also most important causes of unilateral 
blindness, which could be the result of exposure to keratitis, 
induced by lagophtalmia from seventh nerve palsy linked to 
leprosy. ARMD was the 4th cause of bilateral blindness in 
this population of lepers, whose average age was 65 years.
In total, out of 111 patients with visual handicaps, 39 cases 
(35%) were due to leprosy, thus conﬁ  rming the results of 
Mpyet and colleagues2 from northeastern Nigeria, who 
found that one third of blindness is linked to leprosy in this 
population.






Cataract 95 39 135
ARMD 26 18 44
Glaucoma 25 12 37
Phthisis bulbi 20 6 26
Corneal opacities 12 3 15




Active keratitis 2 1 3
Active uveitis 1 1 2
Optic neuropathy 1 2 3
Macular hole 2 – 2
Total 186 85 270
Abbreviation: ARMD, age-related macular degeneration.
Note: Two hundred eyes over 470 were normal.




Phthisis bulbi 26 47.3
Corneal opacities 14 25.4
Secondary cataract 6 11
Secondary glaucoma 4 7.3
Optic neuropathy 3 5.4
Panuveitis 2 3.6
Total 55 100
Note: Fifty-ﬁ  ve eyes for 39 patients.Clinical Ophthalmology 2009:3 198
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Conclusion
The prevalence of visual handicaps in the population of lepers 
in southern Cameroon is very high. The main causes are 
age-related degenerative pathologies; one third of the cases 
are due to leprosy. Leprosy is considered a major problem, 
because low vision and blindness constitute other serious 
problems affecting the quality of life. There is an urgent 
need for ophthalmic care to reduce the prevalence of visual 
handicaps in these particular patients; such care may increase 
their chance of social and economic rehabilitation.
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